YOLFTbeta
35

EASY BIOInc

353810 · KQ · Consumer Non-Cyclicals / Food & Tobacco

5,020.00KRW+10.00 (+0.20%)

Price History

Full chart

Market Stats

Previous Close5,010.00
Open4,995.00
Day Range4,925.00 – 5,060.00
52-Week Range5,305.52 – 8,300.00
Volume82.82K
Market Cap201.47B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield3.62%
Beta1.14
50-Day Avg6,230.20
200-Day Avg6,680.10

About

EASY BIO,Inc. provides specialized piglet feed and feed additives solutions in South Korea and internationally. The company was founded in 2020 and is based in Seoul, South Korea.

Company Details

Financials

Income Statement

Currency: KRW2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue88.12B129.46B155.56B165.39B384.33B476.94B
Growth (%)-+46.91%+20.16%+6.32%+132.39%+24.10%
Cost of Revenue58.46B88.83B108.27B113.37B285.85B355.90B
Gross Profit29.66B40.63B47.28B52.02B98.48B121.04B
Gross Margin33.66%31.39%30.40%31.45%25.62%25.38%
Operating Expense14.46B23.85B31.13B31.39B68.33B76.05B
Operating Income15.20B16.78B16.15B20.63B30.15B44.99B
Operating Margin17.25%12.96%10.38%12.47%7.84%9.43%
EBITDA--17.47B26.98B42.91B54.52B
EBITDA Margin--11.23%16.31%11.16%11.43%
Net Income10.43B10.87B9.13B15.54B19.60B27.78B
Net Income Margin11.83%8.40%5.87%9.40%5.10%5.82%
R&D1.15B1.74B2.43B2.49B3.03B3.12B
R&D as % of Total Revenue1.30%1.35%1.56%1.50%0.79%0.65%
Interest Expense632.95M1.10B1.72B3.22B9.02B7.54B
Interest Expense % of Total Revenue0.72%0.85%1.11%1.95%2.35%1.58%

Balance Sheet

Currency: KRW2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets89.82B117.69B157.81B172.04B360.01B327.47B
Total Liabilities55.78B74.78B107.85B105.87B271.21B213.92B
Total Equity34.04B42.92B49.96B62.78B83.97B107.19B
Cash20.45B562.60M464.31M29.07B59.86B60.39B
Total Debt35.73B-----
Net Debt16.37B29.45B41.17B52.21B148.67B91.39B

Cash Flow

Currency: KRW2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow24.70B14.07B-8.12B33.68B25.76B34.65B
Investing Cash Flow-788.18M-20.06B513.77M-41.34B-101.09B-
Financing Cash Flow-649.55M6.23B27.88B-3.41B104.83B-
Capital Expenditure1.82B1.83B2.05B1.96B4.28B6.30B
Free Cash Flow15.25B12.23B-10.17B31.72B21.48B28.35B
Dividends Paid-2.56B2.56B2.63B3.41B6.69B
FCF to OCF61.75%86.93%125.22%94.17%83.39%81.81%
Dividend Paid to FCF-20.94%-25.17%8.28%15.89%23.59%

Earnings

Report DateAug 13, 2020Nov 16, 2020Mar 23, 2021May 17, 2021Aug 17, 2021Nov 15, 2021Mar 23, 2022Mar 31, 2022Jun 30, 2022Sep 30, 2022Mar 23, 2023Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-------------------------
EPS Actual82.64138.5283.9791.0077.0078.0072.3361.7762.8073.0264.42109.72102.32104.49138.81137.12127.42183.08131.62167.79114.51251.18306.19338.18308.15
Surprise-------------------------
TimingPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-market---Pre-market--------------

Key Statistics & Ratios

Market Cap201.47B
Enterprise Value332.34B
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.39
Price / Book1.61
Revenue (TTM)149.87B
Gross Profit (TTM)40.07B
EBITDA20.00B
Profit Margin6.27%
Operating Margin10.72%
Return on Equity2788.04%
Return on Assets6.55%
Shares Outstanding0
Shares Float17.89M
Beta1.14
Dividend Yield3.62%
Dividend Rate0.00
Payout Ratio20.77%

Dividends

20261×
250.00Mar 9, 2026
20241×
200.00Dec 27, 2024
20231×
100.00Dec 27, 2023
20221×
75.00Dec 28, 2022
20211×
75.00Dec 29, 2021
20201×
15.00Dec 29, 2020

Stock Splits

  • Jan 7, 20215:1
  • Nov 11, 2020959692:319897